EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anti-Fungal (Aspergillus fumigatus) Activity of Pseudomonas aeruginosa in Cystic Fibrosis Synthetic Sputum

Gabriele Sass, Satya Kethineni, David A Stevens

Pathogens · 2024

DOI: 10.3390/pathogens13100875 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2024. Verfasst von Gabriele Sass und 2 weiteren Autor:innen. Beteiligte Einrichtung: California Institute for Medical Research, San Jose, CA 95128, USA. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Cystic Fibrosis, Aspergillus fumigatus, Sputum. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation for Research in Infectious Diseases (FRID).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aspergillus fumigatus (Af) and Pseudomonas aeruginosa (Pa) are pathogens inhabiting the lungs of persons with cystic fibrosis (CF), or immune-compromised patients, causing or aggravating disease. We previously investigated their microbial interaction as well as susceptibility to anti-fungal drugs using RPMI medium (contains undetectable iron concentrations), as is standard for susceptibility testing. Here we investigated microbial interaction in synthetic sputum medium (SSPM), a complex mixture designed to mimic the milieu in CF lungs. SSPM contains Fe2+. Pa laboratory strain PA14 or PA14 siderophore mutant planktonic culture filtrate, prepared in RPMI or SSPM, were compared for inhibition of Af biofilm formation. SSPM enhanced bacterial and fungal growth and the production of the Pa molecules pyoverdine, phenazines, and rhamnolipids. Af was more susceptible to these molecules in SSPM (with the exception of pyoverdine). SSPM interfered with fungal susceptibility to pyoverdine. Studies with the mutant helped to reveal that the reduced anti-fungal activity of pyoverdine in SSPM appears to be compensated by higher production of other anti-fungal molecules, e.g., rhamnolipids, phenazines, and PQS, and higher Af sensitivity to these molecules. In summary, SSPM better defines Pa–Af intermicrobial competition in the milieu of CF lungs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pseudomonas aeruginosaCystic FibrosisAspergillus fumigatusSputumBiofilmsAntifungal AgentsGlycolipidsHumansPseudomonas InfectionsMicrobial Sensitivity TestsOligopeptidesPhenazinesMicrobial InteractionsCulture Media

Stichwörter der Autor:innen

Aspergillus fumigatusPseudomonas aeruginosacystic fibrosisfungal biofilmmicrobial interactionpyoverdinesynthetic sputum

Substanzen

rhamnolipidAntifungal AgentspyoverdinGlycolipidsOligopeptidesPhenazinesCulture Media

Autor:innen und Institutionen

  • California Institute for Medical Research, San Jose, CA 95128, USA.
  • Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.

Förderung

  • Foundation for Research in Infectious Diseases (FRID)

Zitieren

APA

Sass, G., Kethineni, S., & Stevens, D. A. (2024). Anti-Fungal (Aspergillus fumigatus) Activity of Pseudomonas aeruginosa in Cystic Fibrosis Synthetic Sputum. Pathogens. https://doi.org/10.3390/pathogens13100875

Vancouver

Sass G, Kethineni S, Stevens DA. Anti-Fungal (Aspergillus fumigatus) Activity of Pseudomonas aeruginosa in Cystic Fibrosis Synthetic Sputum. Pathogens. 2024. doi:10.3390/pathogens13100875

BibTeX
@article{Sass2024,
  author = {Sass, Gabriele and Kethineni, Satya and Stevens, David A},
  title = {Anti-Fungal (Aspergillus fumigatus) Activity of Pseudomonas aeruginosa in Cystic Fibrosis Synthetic Sputum},
  journal = {Pathogens},
  year = {2024},
  doi = {10.3390/pathogens13100875}
}
Kostenlos starten →